Novartis AG vs Clear Secure Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Clear Secure Inc trades at $57.03 (market cap $5.76B). The key difference: Novartis AG is far larger — about 50.4× Clear Secure Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | YOU | |
|---|---|---|
Market Cap | $290.25B | $5.76B |
Sector | Health | Technology |
52-Week High | $168.62 | $62.36 |
52-Week Low | $113.50 | $28.84 |
Enterprise Value | $330.27B | $5.07B |
Dividend Yield | 3.17% | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →